Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mitochondrial proton transport machinery is a sophisticated assembly of protein complexes located in the inner mitochondrial membrane, primarily responsible for the generation and utilization of the electrochemical proton gradient (Nature Reviews Molecular Cell Biology, 2018). This system includes the electron transport chain (ETC) complexes I, III, and IV, which pump protons into the intermembrane space, and ATP synthase (Complex V), which harnesses the proton motive force to synthesize ATP (Frontiers in Physiology, 2019). Additionally, uncoupling proteins (UCPs) within this machinery allow protons to leak back into the matrix, bypassing ATP synthesis to generate heat, a process known as thermogenesis (Cell Metabolism, 2017). Pharmacological targeting of this machinery, particularly through mitochondrial uncouplers like DNP or BAM15, is being explored to treat metabolic disorders such as obesity and type 2 diabetes by increasing energy expenditure (Nature Reviews Drug Discovery, 2020). Conversely, inhibitors of the ETC are investigated in oncology to exploit the metabolic vulnerabilities of cancer cells, though such interventions require careful management to avoid systemic toxicity and hyperthermia (Journal of Clinical Investigation, 2013). The machinery also plays a pivotal role in regulating reactive oxygen species (ROS) and apoptosis, making it a central hub for cellular health and disease (Cell, 2012).
The machinery functions by uncoupling oxidative phosphorylation, dissipating the mitochondrial proton gradient, or inhibiting specific complexes within the electron transport chain to modulate ATP production and metabolic flux.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial proton transport machinery.